Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and Taiwan

Condition:   Rheumatoid Arthritis Interventions:   Drug: Methotrexate;   Drug: Adalimumab Sponsors:   Keio University;   Eisai Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials